Donepezil and Galantamine both come up in the same conversations; they overlap on Acetylcholine. Donepezil: Donepezil is a medication used to treat the symptoms of dementia in Alzheimer's disease. Galantamine: Galantamine is a plant-derived alkaloid, isolated from snowdrops and related plants of the Amaryllidaceae family, used to treat the memory and thinking difficulties of mild-to-moderate Alzheimer's disease.
Donepezil is a medication used to treat the symptoms of dementia in Alzheimer's disease. It belongs to a class of drugs called cholinesterase inhibitors, which work by boosting levels of the signaling chemical acetylcholine in the brain. Developed by the Japanese company Eisai and approved in the United States in 1996 under the brand name Aricept, it is one of the most widely prescribed treatments for Alzheimer's dementia. Donepezil eases symptoms modestly but does not stop or reverse the underlying disease.
Galantamine is a plant-derived alkaloid, isolated from snowdrops and related plants of the Amaryllidaceae family, used to treat the memory and thinking difficulties of mild-to-moderate Alzheimer's disease. It has an unusual dual action on the cholinergic system: it inhibits the enzyme acetylcholinesterase, and it separately acts as an allosteric potentiating ligand that binds a site distinct from the neurotransmitter's on nicotinic acetylcholine receptors, making them respond more strongly to acetylcholine. Marketed under names such as Razadyne and Reminyl, it has also been studied as a nerve-agent countermeasure and, more curiously, as an aid to lucid dreaming.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
selective inhibitor
Reversible inhibitor
strengthens
agonist
slows
Allosteric potentiator
Slower
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.